Biocon Biologics Promotes Shreehas Tambe As The Chief

Shreehas Tambe was previously Deputy CEO of Biocon Biologics.

New Delhi:

Biocon Biologics today said it has elevated Shreehas Tambe as Managing Director and CEO (Chief Executive Officer) of the company with immediate effect.

Shreehas Tambe was Deputy CEO of Biocon Biologics, a subsidiary of Bengaluru-based Biocon.

He takes over from Arun Chandavarkar, who will continue to serve as a non-executive, non-independent director on the Biocon Biologics board, the company said in a statement.

“Shreehas is taking on the responsibility of leading Biocon Biologics as MD & CEO at a time when the company is gearing up for global leadership in biosimilars with the closing of the Viatris acquisition,” Biocon & Biocon Biologics Executive Chairperson Kiran Mazumdar-Shaw said.

Shreehas will be aided by a highly experienced executive leadership team in building a future-ready, world leading biosimilars player and a well-recognised global brand that is committed to impacting global healthcare, she added.

Shreehas Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)